PSMA-targeted PET imaging agent

0 marketed 2 in Phase 3

This page covers all PSMA-targeted PET imaging agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PSMA (prostate-specific membrane antigen).

Targets

PSMA (prostate-specific membrane antigen)

Phase 3 pipeline (2)

Radiopharmaceutical 18F-JK-PSMA-7 · ITEL Telecomunicazioni Srl · Oncology
18F-JK-PSMA-7 is a fluorine-18 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.
18F-PSMA-1007 · Affiliated Hospital of Jiangnan University · Oncology
18F-PSMA-1007 is a fluorine-18 labeled small molecule that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.